About the Editors
Editor-in-Chief
Magdalene Montgomery, PhD
University of Melbourne
Melbourne, VIC, Australia
Dr Magda Montgomery is a senior lecturer in the Department of Anatomy and Physiology, University of Melbourne, and previous Fellow of the National Health and Medical Research Council of Australia. Dr Montgomery leads an innovative research program aimed at understanding how defects in lipid metabolism and the endocrine function of the liver drive progression of liver disease and type 2 diabetes. Dr Montgomery received her PhD at the University of Wollongong in 2011, and her postdoctoral training in the area of obesity, insulin resistance and non-alcoholic fatty liver disease (NAFLD) at the Garvan Institute in Sydney, at the University of New South Wales, and at Monash University (Australia). In 2018, Dr Montgomery moved to the University of Melbourne, where she is currently investigating links between perturbations in liver homeostasis and the development of type 2 diabetes.
Associate Editors
Molecular Aging Program, Department of Cellular and Molecular Medicine, University of Copenhagen,
Copenhagen, Denmark
Brenna Osborne is an Assistant Professor at the Center for Healthy Aging, University of Copenhagen, Denmark. Brenna completed her PhD at the Garvan Institute of Medical Research in Sydney, Australia in 2015 studying the role of sirtuins in high fat diet induced obesity and diabetes. Brenna relocated to Denmark in 2018 and has been working at the Center for Healthy Aging focusing on using mouse models to investigate the crossroads of metabolic dysfunction and ageing with a focus on NAD+ biology.
Kevin B. Koronowski, PhD
UT Health San Antonio,
San Antonio, TX, USA
My laboratory project aims to better our understanding of how metabolism is regulated across time (over the course of a day) and space (between cells and organs of the body). Acquiring this knowledge will help identify root causes of, and potential therapies for, metabolic diseases such as obesity, metabolic syndrome, type 2 diabetes and cancer. We model metabolic health and disease in cultured cells and mice using environmental, dietary and genetic tools that disrupt the circadian clock, a biological system tied to metabolic health. We employ cutting-edge techniques in metabolomics, molecular biology and in vivo metabolism.
Jane Reznick, PhD
CECAD Research Center/ University Hospital Cologne,
Cologne, Germany
My lab works with the naked mole-rat, a eusocial mammal which has evolved various adaptations towards its hostile subterranean environment and which simultaneously protect this species against various diseases like cancer to promote exceptional longevity (> 35 years). We focus on metabolic innovations in the naked mole-rat which protect them against injuries associated with ischaemia/reperfusion. Via investigation of the metabolome, proteome and epigenetic regulation of genes, we seek to understand advantageous metabolic rewiring which we subsequently test in mouse models.
Carlos Manlio Díaz García, PhD
University of Oklahoma Health Sciences Center,
Oklahoma City, OK, USA
My laboratory studies the mechanisms linking neuronal activity to energy metabolism, with emphasis on intracellular Ca2+ dynamics and their impact on neuronal glycolysis and mitochondrial function. We are also interested in the regulatory effects of hormones and circulating metabolites on brain metabolism, and their roles in the etiology of cognitive aging. In this context, we also investigate the metabolic tuning and fuel flexibility in synaptic compartments, as well as in different neural cell types. Our approaches include the quantitative assessment of cellular metabolism using genetically encoded fluorescent biosensors, in combination with multiphoton microscopy and fluorescence lifetime imaging.
Carolina M. Greco, PhD
Humanitas University and IRCCS Humanitas Research Hospital,
Milan, Italy
My research focuses on circadian biology and metabolism in cardiovascular disease, mainly heart failure (HF). Using experimental models of HF, we aim to elucidate how metabolism intersects with the epigenetic landscape of the failing heart and how the heart affects metabolism in peripheral tissues to alter disease progression.
Lucas Sullivan, PhD
Fred Hutchinson Cancer Center
Seattle, WA, USA
My laboratory studies the metabolic constraints of cell proliferation. We investigate mechanisms by which alterations to metabolism, such as mitochondrial function, metabolite scavenging, and levels of intrinsically reactive metabolites, can impact cell proliferation through changes in metabolic homeostasis and signaling. Ultimately, we aim to generate discoveries that inform novel metabolic therapeutic approaches for human diseases, including cancer, mitochondrial diseases, and others.
Advisory Editors
Ashley Castellanos-Jankiewicz, PhD
Ashley joined Nature Metabolism in February 2021. With a background in human nutrition, she pursued a MSc in Fundamental Neuroscience from Maastricht University in order to explore the central mechanisms driving energy homeostasis. She then obtained her PhD in Neuroscience from the University of Bordeaux by studying the hypothalamic role of bile acids on energy balance in the context of obesity. Ashley is based in the New York office and you can follow her on Twitter @ash_castjan
Francesca La Rosa, PhD
Francesca joined Nature Communications in May 2023. She received her PhD in Genetics, Molecular and Cellular Biology from the University of Pavia including an exchange experience at the Spanish National Centre for Cardiovascular Research in Madrid. Her research background is in molecular cardiology, cardiac metabolism, and gene therapy. She primarily handles papers in the fields of metabolic diseases, hepatology, endocrinology, and gastroenterology. She is based in the Madrid office.
Editorial Board Members
Sreenivasulu Basha, PhD
Tulane University
New Orleans, Louisiana, USA
J. Brian Byrd, MD, MS
University of Michigan Medical School
Ann Arbor, MI, USA
Emily Jane Gallagher, MD, PhD
Icahn School of Medicine at Mount Sinai
New York, NY, USA
Angelika B. Harbauer, PhD
Max-Planck-Institute for Biological Intelligence
Munich, Germany
Emily Nicole C. Manoogian, PhD
Salk Institute for Biological Studies
La Jolla, CA, USA
Carmelo Quarta, PhD
University of Bordeaux
Bordeaux, France
Feng Rao, PhD
Southern University of Science and Technology
Shenzhen, Guangdong, China
Lauren Marie Sparks, PhD
Translational Research Institute, AdventHealth
Orlando, FL
Krista A. Varady, PhD
University of Illinois Chicago
Chicago, IL, USA
Kyle S. McCommis, PhD
Saint Louis University School of Medicine
St. Louis, MO, USA
Lu Wang, PhD
UT Health San Antonio
San Antonio, TX, USA
Sreemathi Logan, PhD
University of Oklahoma Health Sciences Center
Oklahoma City, OK, USA
Feilong Wang, MD
Shanghai East Hospital, School of Medicine, Tongji University
Shanghai, China
Maria Luisa Malosio, PhD
Institute of Neuroscience, CNR and IRCCS Humanitas Research Hospital
Milan, Italy
Vijay C. Ganta, PhD
Medical College of Georgia at Augusta University
Augusta, GA, USA
Benjamin Leo Parker, PhD
The University of Melbourne
Melbourne, Australia
Daiqing Liao, PhD
University of Florida
Gainesville, FL, USA
Rodrigo Mancilla Fuentes, PhD
Maastricht University and Finis Terrae University
Maastricht, The Netherlands
Luiza Martins Nascentes Melo, PhD
University Hospital Essen
Essen, NRW, Germany
Frederic Gachon, PhD
The University of Queensland
Brisbane, Australia
Peter James Mullen, PhD
University of Southern California
Los Angeles, CA, USA
Filipe Cabreiro, PhD
CECAD Research Cluster - University of Cologne
Cologne, Germany
Javier Gonzalez, PhD
University of Bath
Bath, UK
Rula Bany Bakar, PhD
University of Cambridge, Department of Medicine
Cambridge, UK
Alexis A. Jourdain, PhD
University of Lausanne
Lausanne, Switzerland
Christian Frezza, PhD
University of Cologne, Faculty of Medicine
Cologne, Germany
Eun-Jung Jin, PhD
Wonkwang University
Iksan, South Korea
Richa Batra, PhD
Weill Cornell Medicine
New York, NY, USA
Kristin K. Brown, PhD
Peter MacCallum Cancer Centre
Melbourne, Australia
Matthijs K. Hesselink, PhD
Maastricht University Medical Center
Maastricht, The Netherlands
Emma Louise Robinson, PhD
University of Colorado, Anschutz Medical Campus
Aurora, CO, USA
Andrew J. Hoy, PhD
The University of Sydney
Sydney, Australia
Jacob G. Smith, PhD
Universitat Pompeu Fabra
Barcelona, Spain
Xingguo Liu, PhD
Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences
Guangzhou, Guangdong Province, China
Peter Aldiss, PhD
NIHR Nottingham Biomedical Research Centre & Nottingham Biodiscovery Institute, University of Nottingham
Nottingham, UK
Amanda Brandon, PhD
University of Sydney
Sydney, Australia
Interested in joining the journal team?
If you are interested in joining the journal as an Editorial Board Member or Associate Editor, please complete this Google form. Associate Editors are part of the editorial team that handle manuscripts, while Editorial Board Members are regular reviewers and are consulted for ad hoc advice. We will contact you if your expertise meets the needs of the journal.
Nature Portfolio journals are committed to promoting practices that support diversity, equity and inclusion in science communication and publishing, and we strongly encourage gender, race, ethnic, geographic, career stage and other diversity in our journal teams. Our in-house staff will use your information only for the purposes of identifying new editorial team or board members. Please contact the journal by email if you would like to remove your information from these records.
Please note that we are not able to respond to all applicants.
